Global Artificial Intelligence Drug R&D Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Artificial Intelligence Drug R&D market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Artificial Intelligence Drug R&D business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug R&D market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Artificial Intelligence Drug R&D, covering the supply chain analysis, impact assessment to the Artificial Intelligence Drug R&D market size growth rate in several scenarios, and the measures to be undertaken by Artificial Intelligence Drug R&D companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
AI Platfrom
Analytics Service
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Drug Discovery
Precision Medicine
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
IBM Watson
Phenomic AI
BioXel
Gatehouse Bio
Google DeepMind
Insilico Medicine
QuantumBlack
Genpact Cora
Nq Medical
Cyclica Inc
Palantir Technologies
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Artificial Intelligence Drug R&D market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Artificial Intelligence Drug R&D market by identifying its various subsegments.
Focuses on the key global Artificial Intelligence Drug R&D players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artificial Intelligence Drug R&D with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Artificial Intelligence Drug R&D submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug R&D Market Size 2015-2025
2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region
2.2 Artificial Intelligence Drug R&D Segment by Type
2.2.1 AI Platfrom
2.2.2 AI Platfrom
2.3 Artificial Intelligence Drug R&D Market Size by Type
2.3.1 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2015-2020)
2.3.2 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type (2015-2020)
2.4 Artificial Intelligence Drug R&D Segment by Application
2.4.1 Drug Discovery
2.4.2 Precision Medicine
2.5 Artificial Intelligence Drug R&D Market Size by Application
2.5.1 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2015-2020)
2.5.2 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Application (2015-2020)
3 Global Artificial Intelligence Drug R&D by Players
3.1 Global Artificial Intelligence Drug R&D Market Size Market Share by Players
3.1.1 Global Artificial Intelligence Drug R&D Market Size by Players (2018-2020)
3.1.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Players (2018-2020)
3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence Drug R&D by Regions
4.1 Artificial Intelligence Drug R&D Market Size by Regions
4.2 Americas Artificial Intelligence Drug R&D Market Size Growth
4.3 APAC Artificial Intelligence Drug R&D Market Size Growth
4.4 Europe Artificial Intelligence Drug R&D Market Size Growth
4.5 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth
5 Americas
5.1 Americas Artificial Intelligence Drug R&D Market Size by Countries
5.2 Americas Artificial Intelligence Drug R&D Market Size by Type
5.3 Americas Artificial Intelligence Drug R&D Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Artificial Intelligence Drug R&D Market Size by Regions
6.2 APAC Artificial Intelligence Drug R&D Market Size by Type
6.3 APAC Artificial Intelligence Drug R&D Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Artificial Intelligence Drug R&D by Countries
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence Drug R&D by Countries
8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type
8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Artificial Intelligence Drug R&D Market Forecast
10.1 Global Artificial Intelligence Drug R&D Market Size Forecast (2021-2025)
10.2 Global Artificial Intelligence Drug R&D Forecast by Regions
10.2.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Artificial Intelligence Drug R&D Forecast by Type
10.8 Global Artificial Intelligence Drug R&D Forecast by Application
11 Key Players Analysis
11.1 IBM Watson
11.1.1 Company Details
11.1.2 Artificial Intelligence Drug R&D Product Offered
11.1.3 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 IBM Watson News
11.2 Phenomic AI
11.2.1 Company Details
11.2.2 Artificial Intelligence Drug R&D Product Offered
11.2.3 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Phenomic AI News
11.3 BioXel
11.3.1 Company Details
11.3.2 Artificial Intelligence Drug R&D Product Offered
11.3.3 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 BioXel News
11.4 Gatehouse Bio
11.4.1 Company Details
11.4.2 Artificial Intelligence Drug R&D Product Offered
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Gatehouse Bio News
11.5 Google DeepMind
11.5.1 Company Details
11.5.2 Artificial Intelligence Drug R&D Product Offered
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Google DeepMind News
11.6 Insilico Medicine
11.6.1 Company Details
11.6.2 Artificial Intelligence Drug R&D Product Offered
11.6.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Insilico Medicine News
11.7 QuantumBlack
11.7.1 Company Details
11.7.2 Artificial Intelligence Drug R&D Product Offered
11.7.3 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 QuantumBlack News
11.8 Genpact Cora
11.8.1 Company Details
11.8.2 Artificial Intelligence Drug R&D Product Offered
11.8.3 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Genpact Cora News
11.9 Nq Medical
11.9.1 Company Details
11.9.2 Artificial Intelligence Drug R&D Product Offered
11.9.3 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Nq Medical News
11.10 Cyclica Inc
11.10.1 Company Details
11.10.2 Artificial Intelligence Drug R&D Product Offered
11.10.3 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Cyclica Inc News
11.11 Palantir Technologies
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Artificial Intelligence Drug R&D Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of AI Platfrom
Table 5. Major Players of Analytics Service
Table 6. Artificial Intelligence Drug R&D Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2015-2020)
Table 8. Global Artificial Intelligence Drug R&D Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2015-2020)
Table 10. Global Artificial Intelligence Drug R&D Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2018-2020)
Table 12. Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
Table 13. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Artificial Intelligence Drug R&D Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions 2015-2020
Table 18. Americas Artificial Intelligence Drug R&D Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Artificial Intelligence Drug R&D Market Size Market Share by Countries (2015-2020)
Table 20. Americas Artificial Intelligence Drug R&D Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2015-2020)
Table 22. Americas Artificial Intelligence Drug R&D Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2015-2020)
Table 24. APAC Artificial Intelligence Drug R&D Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Artificial Intelligence Drug R&D Market Size Market Share by Regions (2015-2020)
Table 26. APAC Artificial Intelligence Drug R&D Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2015-2020)
Table 28. APAC Artificial Intelligence Drug R&D Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2015-2020)
Table 30. Europe Artificial Intelligence Drug R&D Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Artificial Intelligence Drug R&D Market Size Market Share by Countries (2015-2020)
Table 32. Europe Artificial Intelligence Drug R&D Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2015-2020)
Table 34. Europe Artificial Intelligence Drug R&D Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Artificial Intelligence Drug R&D
Table 43. Key Application and Potential Industries of Artificial Intelligence Drug R&D
Table 44. Key Challenges of Artificial Intelligence Drug R&D
Table 45. Key Trends of Artificial Intelligence Drug R&D
Table 46. Global Artificial Intelligence Drug R&D Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Regions
Table 48. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2021-2025)
Table 52. IBM Watson Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 53. IBM Watson Artificial Intelligence Drug R&D Product Offered
Table 54. IBM Watson Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 55. IBM Watson Main Business
Table 56. IBM Watson Latest Developments
Table 57. Phenomic AI Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 58. Phenomic AI Artificial Intelligence Drug R&D Product Offered
Table 59. Phenomic AI Main Business
Table 60. Phenomic AI Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 61. Phenomic AI Latest Developments
Table 62. BioXel Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 63. BioXel Artificial Intelligence Drug R&D Product Offered
Table 64. BioXel Main Business
Table 65. BioXel Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 66. BioXel Latest Developments
Table 67. Gatehouse Bio Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 68. Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
Table 69. Gatehouse Bio Main Business
Table 70. Gatehouse Bio Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 71. Gatehouse Bio Latest Developments
Table 72. Google DeepMind Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 73. Google DeepMind Artificial Intelligence Drug R&D Product Offered
Table 74. Google DeepMind Main Business
Table 75. Google DeepMind Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 76. Google DeepMind Latest Developments
Table 77. Insilico Medicine Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 78. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
Table 79. Insilico Medicine Main Business
Table 80. Insilico Medicine Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 81. Insilico Medicine Latest Developments
Table 82. QuantumBlack Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 83. QuantumBlack Artificial Intelligence Drug R&D Product Offered
Table 84. QuantumBlack Main Business
Table 85. QuantumBlack Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 86. QuantumBlack Latest Developments
Table 87. Genpact Cora Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 88. Genpact Cora Artificial Intelligence Drug R&D Product Offered
Table 89. Genpact Cora Main Business
Table 90. Genpact Cora Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 91. Genpact Cora Latest Developments
Table 92. Nq Medical Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 93. Nq Medical Artificial Intelligence Drug R&D Product Offered
Table 94. Nq Medical Main Business
Table 95. Nq Medical Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 96. Nq Medical Latest Developments
Table 97. Cyclica Inc Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
Table 98. Cyclica Inc Artificial Intelligence Drug R&D Product Offered
Table 99. Cyclica Inc Main Business
Table 100. Cyclica Inc Artificial Intelligence Drug R&D Revenue and Gross Margin (2018-2020E)
Table 101. Cyclica Inc Latest Developments
Table 102. Palantir Technologies Details, Company Total Revenue (in $ million), Head Office, Artificial Intelligence Drug R&D Major Market Areas and Its Competitors
List of Figures
Figure 1. Artificial Intelligence Drug R&D Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Artificial Intelligence Drug R&D Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2015-2020)
Figure 5. Global AI Platfrom Market Size Growth Rate
Figure 6. Global Analytics Service Market Size Growth Rate
Figure 7. Artificial Intelligence Drug R&D in Drug Discovery
Figure 8. Global Artificial Intelligence Drug R&D Market: Drug Discovery (2015-2020) ($ Millions)
Figure 9. Artificial Intelligence Drug R&D in Precision Medicine
Figure 10. Global Artificial Intelligence Drug R&D Market: Precision Medicine (2015-2020) ($ Millions)
Figure 11. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2019
Figure 12. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions 2015-2020
Figure 13. Americas Artificial Intelligence Drug R&D Market Size 2015-2020 ($ Millions)
Figure 14. APAC Artificial Intelligence Drug R&D Market Size 2015-2020 ($ Millions)
Figure 15. Europe Artificial Intelligence Drug R&D Market Size 2015-2020 ($ Millions)
Figure 16. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2015-2020 ($ Millions)
Figure 17. Americas Artificial Intelligence Drug R&D Market Size Market Share by Countries in 2019
Figure 18. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type in 2019
Figure 19. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application in 2019
Figure 20. United States Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 21. Canada Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 22. Mexico Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 23. APAC Artificial Intelligence Drug R&D Market Size Market Share by Regions in 2019
Figure 24. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type in 2019
Figure 25. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application in 2019
Figure 26. China Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 27. Japan Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 28. Korea Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 29. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 30. India Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 31. Australia Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 32. Europe Artificial Intelligence Drug R&D Market Size Market Share by Countries in 2019
Figure 33. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type in 2019
Figure 34. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application in 2019
Figure 35. Germany Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 36. France Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 37. UK Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 38. Italy Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 39. Russia Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 40. Spain Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Countries in 2019
Figure 42. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type in 2019
Figure 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application in 2019
Figure 44. Egypt Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 45. South Africa Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 46. Israel Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 47. Turkey Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 48. GCC Countries Artificial Intelligence Drug R&D Market Size Growth 2015-2020 ($ Millions)
Figure 49. Global Artificial Intelligence Drug R&D arket Size Forecast (2021-2025) ($ Millions)
Figure 50. Americas Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 51. APAC Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 52. Europe Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 53. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 54. United States Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 55. Canada Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 56. Mexico Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 57. Brazil Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 58. China Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 59. Japan Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 60. Korea Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 61. Southeast Asia Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 62. India Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 63. Australia Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 64. Germany Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 65. France Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 66. UK Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 67. Italy Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 68. Russia Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 69. Spain Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 70. Egypt Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 71. South Africa Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 72. Israel Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 73. Turkey Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
Figure 74. GCC Countries Artificial Intelligence Drug R&D Market Size 2021-2025 ($ Millions)
